Strict regulation of the use of AI - priority for the benefit of humanity

George Marinescu
English Section / 19 septembrie

Specialists in the legal field argue that the situation of using AI in the pharma industry becomes a high-risk one, if the research-innovation of some therapies or drugs will be carried out with the new technology.

Specialists in the legal field argue that the situation of using AI in the pharma industry becomes a high-risk one, if the research-innovation of some therapies or drugs will be carried out with the new technology.

Versiunea în limba română

The development of the IT&C sector, the Internet of Things (IoT) and Artificial Intelligence (AI) represents a huge challenge for the entire global economy, a challenge that must be carefully managed and strictly regulated in order not to allow any slippage from well-established ethical criteria, for not to endanger the safety of citizens and their lives.

Specialists in the legal field argue that the situation of using AI in the pharma industry becomes a high-risk one, if the research-innovation of some therapies or drugs will be carried out with the new technology.

Lawyer Gheorghe Piperea, PhD professor at the Faculty of Law of the University of Bucharest told us: "At this moment, Artificial Intelligence takes over from the databases and errors or mistakes. For example, the use of AI in the legal field, to facilitate the work performed by judges, prosecutors, clerks or lawyers, could lead to serious errors in taking preventive measures, in seizing or in pronouncing definitive judicial decisions, through the lens of errors slipped into the final decisions of the courts of the past, decisions that would be scanned and entered into the vast legal database that would be used by artificial intelligence. There are situations where judicial precedent applies, but some precedents are wrong or outdated, or if we let AI search in that database it will call on them, and today's or tomorrow's magistrates could pronounce totally erroneous decisions with serious consequences on litigants, on the notion of justice. Then there are some matters of judgment, emotion, conscience, ethics, qualities that Artificial Intelligence does not have. For example, in cases concerning the custody of minors, statistics show that out of 100 requests, in 80% of cases the child is entrusted to the mother and only 20% is entrusted to the father. The AI will not actually check how the parent relates to the minor in each case and, based on the statistics, would entrust the child to the mother. This is also the situation in the case of the pharma industry that you presented in the pages of the BURSA Newspaper. Using AI to make drugs or treatments runs the risk of the new technology calling on old databases that also contain errors, a risk that could turn all the world's citizens into patients from birth. For example, the timing of diagnosing a person from a psychological or psychiatric point of view cannot be left to Artificial Intelligence, because there is a risk that a healthy person will be declared insane or with various mental conditions and subjected to drug treatment that will have consequences negative about him. That is why it is necessary that the use of AI in certain economic fields, in the field of health and in justice, is strictly regulated, on well-defined ethical principles, which, if violated, attract serious sanctions for those who misuse or maliciously use the new technologies ".

The legal specialist also told us that this is the only way to avoid cases in which teenagers find themselves labeled as hypertensive, middle-aged people as suffering from osteoporosis or other diseases specific to the third age, or in which new diseases appear, which no one has heard of, but for which the pharma industry has prepared the related treatment.

It is certain that our journalistic approach in recent days represents nothing more than a warning for political decision-makers, the only ones who can strictly regulate new technologies so that their use is for the benefit of humanity and not to its detriment.

Cotaţii Internaţionale

vezi aici mai multe cotaţii

Bursa Construcţiilor

www.constructiibursa.ro

www.agerpres.ro
www.dreptonline.ro
www.hipo.ro

adb